Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Latest News about BMRN

Recent news which mentions BMRN

< Previous 1 2 3 4 5 6 7 8 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tickers ADAP APOP BMRN FWP
Tags APOP PLRX BZI/TFM
From Benzinga
FDA Slaps Clinical Hold on BioMarin's Gene Therapy For Genetic Metabolism Disorder
Tickers BMRN
Tags BMRN gene therapy Market News
From Benzinga
Drug For Short-Limbed Dwarfism From Biomarin Wins European Approval
Tickers BMRN
Tags achondroplasia Benzinga Market News
From Benzinga
Get Ready for a Potential Double in This Biopharmaceutical Stock in the Next 6 to 12 Months
Tickers ASND BMRN
Tags BMRN ASND Market News
From Motley Fool
BioMarin Bounces Back With Solid Q2 Earnings, Nudges Up 2021 Guidance
Tickers BMRN
Tags BMRN Market News General
From Benzinga
BioMarin Pharmaceutical inc (BMRN) Q2 2021 Earnings Call Transcript
Tickers BMRN
Tags BMRN Market News
From Motley Fool
Biomarin Pharmaceutical: Q2 Earnings Insights
Tickers BMRN
Tags Benzinga BZI/Recaps Market News
From Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Tickers ABCL ABOS ACET ACHL
Tags ABOS ARNA MTCR
From Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Tickers ABBV ACIU AGIO AGRX
Tags TVTX MYOV IART
From Benzinga
BioMarin Shares 5-Year Data From Open-Label Trial Of Hemophilia Gene Therapy
Tickers BMRN
Tags Market News Benzinga Phase 2 Trial
From Benzinga
BioMarin Expects EMA's CHMP Opinion In 1H 2022 For Its Hemophilia A Gene Therapy, FDA Resubmission In 2Q'22
Tickers BMRN
Tags Market News Benzinga gene therapy
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.